We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$31B
AUM Growth
+$5.1B
Cap. Flow
+$4.42B
Cap. Flow %
14.26%
Top 10 Hldgs %
15.35%
Holding
1,525
New
241
Increased
776
Reduced
376
Closed
66

Sector Composition

Rank Sector Weight
1 Financials 17.48%
2 Technology 15.7%
3 Healthcare 13.87%
4 Industrials 10.19%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZGNX
1376
DELISTED
Zogenix, Inc.
ZGNX
$275K ﹤0.01%
+19,000
New +$239K
CNA icon
1377
CNA Financial
CNA
$13.7B
$264K ﹤0.01%
5,410
OMF icon
1378
OneMain Financial
OMF
$7.44B
$259K ﹤0.01%
10,529
PGEN icon
1379
Precigen
PGEN
$2.45B
$257K ﹤0.01%
10,682
-310
-3% -$6.8K
ATRA icon
1380
Atara Biotherapeutics
ATRA
$83.1M
$252K ﹤0.01%
+720
New +$277K
NTRA icon
1381
Natera
NTRA
$45.5B
$250K ﹤0.01%
+23,000
New +$225K
KANG
1382
DELISTED
iKang Healthcare Group, Inc.
KANG
$245K ﹤0.01%
20,000
KOS icon
1383
Kosmos Energy
KOS
$1.49B
$243K ﹤0.01%
37,962
+6,710
+21% +$42.6K
CMRE icon
1384
Costamare
CMRE
$1.71B
$241K ﹤0.01%
+32,980
New +$231K
SEB icon
1385
Seaboard Corp
SEB
$4.02B
$240K ﹤0.01%
+60
New +$241K
INSY
1386
DELISTED
Insys Therapeutics, Inc.
INSY
$240K ﹤0.01%
+19,000
New +$225K
HMY icon
1387
Harmony Gold Mining
HMY
$12.4B
$237K ﹤0.01%
143,573
-144,517
-50% -$310K
KPTI icon
1388
Karyopharm Therapeutics
KPTI
$46M
$235K ﹤0.01%
+1,733
New +$256K
BKI
1389
DELISTED
Black Knight, Inc. Common Stock
BKI
$235K ﹤0.01%
+5,728
New +$226K
BLCM
1390
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$234K ﹤0.01%
+2,000
New +$248K
RIGL icon
1391
Rigel Pharmaceuticals
RIGL
$782M
$232K ﹤0.01%
+8,500
New +$233K
PPC icon
1392
Pilgrim's Pride
PPC
$6.4B
$231K ﹤0.01%
10,545
-1,250
-11% -$29.7K
NVAX icon
1393
Novavax
NVAX
$1.31B
$230K ﹤0.01%
+10,000
New +$196K
OKE icon
1394
Oneok
OKE
$58.3B
$230K ﹤0.01%
4,413
-53,167
-92% -$2.75M
ASMB icon
1395
Assembly Biosciences
ASMB
$536M
$227K ﹤0.01%
+917
New +$258K
COLL icon
1396
Collegium Pharmaceutical
COLL
$834M
$225K ﹤0.01%
+18,000
New +$178K
VIV icon
1397
Telefônica Brasil
VIV
$18.5B
$214K ﹤0.01%
15,841
BOLD
1398
DELISTED
Audentes Therapeutics, Inc
BOLD
$210K ﹤0.01%
+11,000
New +$176K
PETX
1399
DELISTED
Aratana Therapeutics, Inc.
PETX
$210K ﹤0.01%
+29,000
New +$178K
AGEN
1400
Agenus
AGEN
$311M
$207K ﹤0.01%
+2,700
New +$190K

Similar funds

State of Wisconsin Investment Board's Q2 2017 Portfolio in Review

As of Q2 2017, State of Wisconsin Investment Board held 1,525 positions worth $31B, up 20% from $25.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

State of Wisconsin Investment Board deployed $4.42B of net new capital in Q2 2017, opening 241 new positions and adding to 776 existing holdings. Its largest new stake was Altaba Inc: 1,221,540 shares worth $66.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $64.5M trimmed.

  • State of Wisconsin Investment Board's largest Q2 2017 buy was Altaba Inc: 1,221,540 shares worth $66.5M.
  • State of Wisconsin Investment Board added most to Apple in Q2 2017, an estimated $132M increase.
  • State of Wisconsin Investment Board's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $64.5M.
  • State of Wisconsin Investment Board fully exited State Street SPDR S&P Biotech ETF in Q2 2017, selling an estimated $105M.
  • State of Wisconsin Investment Board's ten largest holdings make up 15% of its $31B portfolio in Q2 2017.
  • State of Wisconsin Investment Board opened 241 new positions and closed 66 in Q2 2017.
  • State of Wisconsin Investment Board's portfolio value rose 20% quarter-over-quarter to $31B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2017, filed 3 Aug 2017.